Cargando…
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
The arrival of the monoclonal antibody (mAb) technology in the 1970s brought with it the hope of conquering cancers to the medical community. However, mAbs, on the whole, did not achieve the expected wonder in cancer therapy although they do have demonstrated successfulness in the treatment of a few...
Autores principales: | Fu, Zhaoying, Xiang, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215806/ https://www.ncbi.nlm.nih.gov/pubmed/32316469 http://dx.doi.org/10.3390/ijms21082793 |
Ejemplares similares
-
Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
por: Fu, Zhaoying, et al.
Publicado: (2020) -
Nucleic Acid Aptamers in Nanotechnology
por: Sinitsyna, Valentina V., et al.
Publicado: (2022) -
Recent Progress and Opportunities for Nucleic Acid Aptamers
por: Byun, Jonghoe
Publicado: (2021) -
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
por: Xiang, Dongxi, et al.
Publicado: (2015) -
Therapeutic applications of nucleic acid aptamers in microbial infections
por: Afrasiabi, Shima, et al.
Publicado: (2020)